Reinfection of mice with respiratory syncytial virus - PubMed

Reinfection of mice with respiratory syncytial virus

B S Graham et al. J Med Virol. 1991 May.

Erratum in

• J Med Virol 1991 Dec;35(4):307

Abstract

A BALB/c model of respiratory syncytial virus infection has been developed in which high-titered replication occurs in lung, immunological infiltrates in lung can be detected histologically, and illness can be consistently reproduced. The immunodeterminants of RSV reinfection in this system were investigated by rechallenging mice with RSV early (less than 2 months after primary infection) and late (16 to 21 months after primary infection) and correlating illness and titer of RSV isolated from lungs and noses with RSV-specific serological responses and lung histology. After early rechallenge, RSV was cleared within 24 hours from both nose and lung. After late rechallenge, RSV was isolated at 72 hours from nose in 21/24 mice, but from lung in only 5/24 mice. Isolation of RSV from lung after rechallenge was associated with low RSV-specific antibody titers measured by ELISA and plaque-reduction neutralization. The presence of lymphocyte aggregates around the bronchovascular bundles was associated with inability to isolate RSV from lung and lack of illness. The basophilic lymphocytes were small and uniform in size with dense nuclei and a small amount of cytoplasm. These studies demonstrate that nasal and pulmonary reinfection with RSV is possible in mice after late rechallenge. The studies also indicate the potential importance of RSV-specific antibody in protecting lung from reinfection.

Similar articles

• Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

  Graham BS, Bunton LA, Wright PF, Karzon DT. Graham BS, et al. J Clin Invest. 1991 Sep;88(3):1026-33. doi: 10.1172/JCI115362. J Clin Invest. 1991. PMID: 1909350 Free PMC article.

• Primary respiratory syncytial virus infection in mice.

  Graham BS, Perkins MD, Wright PF, Karzon DT. Graham BS, et al. J Med Virol. 1988 Oct;26(2):153-62. doi: 10.1002/jmv.1890260207. J Med Virol. 1988. PMID: 3183639

• Respiratory syncytial virus infection in anti-mu-treated mice.

  Graham BS, Bunton LA, Rowland J, Wright PF, Karzon DT. Graham BS, et al. J Virol. 1991 Sep;65(9):4936-42. doi: 10.1128/JVI.65.9.4936-4942.1991. J Virol. 1991. PMID: 1908028 Free PMC article.

• Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.

  Graham BS, Davis TH, Tang YW, Gruber WC. Graham BS, et al. Pediatr Res. 1993 Aug;34(2):167-72. doi: 10.1203/00006450-199308000-00013. Pediatr Res. 1993. PMID: 8233720

• Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin.

  Graham BS, Tang YW, Gruber WC. Graham BS, et al. J Infect Dis. 1995 Jun;171(6):1468-74. doi: 10.1093/infdis/171.6.1468. J Infect Dis. 1995. PMID: 7769280

Cited by

• Animal pneumoviruses: molecular genetics and pathogenesis.

  Easton AJ, Domachowske JB, Rosenberg HF. Easton AJ, et al. Clin Microbiol Rev. 2004 Apr;17(2):390-412. doi: 10.1128/CMR.17.2.390-412.2004. Clin Microbiol Rev. 2004. PMID: 15084507 Free PMC article. Review.

• Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

  Domachowske JB, Rosenberg HF. Domachowske JB, et al. Clin Microbiol Rev. 1999 Apr;12(2):298-309. doi: 10.1128/CMR.12.2.298. Clin Microbiol Rev. 1999. PMID: 10194461 Free PMC article. Review.

• Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.

  Valosky J, Hishiki H, Zaoutis TE, Coffin SE. Valosky J, et al. Clin Diagn Lab Immunol. 2005 Jan;12(1):171-9. doi: 10.1128/CDLI.12.1.171-179.2005. Clin Diagn Lab Immunol. 2005. PMID: 15643003 Free PMC article.

• Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.

  Olson MR, Varga SM. Olson MR, et al. Expert Rev Vaccines. 2008 Oct;7(8):1239-55. doi: 10.1586/14760584.7.8.1239. Expert Rev Vaccines. 2008. PMID: 18844597 Free PMC article. Review.

• Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.

  Martinez-Sobrido L, Gitiban N, Fernandez-Sesma A, Cros J, Mertz SE, Jewell NA, Hammond S, Flano E, Durbin RK, García-Sastre A, Durbin JE. Martinez-Sobrido L, et al. J Virol. 2006 Feb;80(3):1130-9. doi: 10.1128/JVI.80.3.1130-1139.2006. J Virol. 2006. PMID: 16414990 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley